Exscientia selects Milton Park for new laboratories
Published on 4 August 2021
Exscientia, a leading artificial intelligence (AI)-driven pharmatech company, has chosen Milton Park as its base as it expands its footprint in Oxfordshire.
Exscientia chose us as the location to expand its footprint thanks to our impressive life sciences ecosystem, strong community collaboration and long-term track record of nurturing businesses.
Founded in 2012, Exscientia utilises AI-led technology to discover and design medicines and treatments faster and more efficiently than through conventional methods. The expansion will see the firm occupy 20,151sq ft of laboratory and office space at 155 Brook Drive, which is part of the Science Vale Enterprise Zone.
Andrew Hopkins, CEO at Exscientia, said: “We’re delighted to have chosen Milton Park for new laboratories as part of the next stage of our business growth. This new, state-of-the-art space is the ideal location for Exscientia as we bring more highly-skilled people into the business with the ability to deploy and continue to develop innovative technology to create new medicines and treatments faster and more efficiently, benefitting patients worldwide.”
Tom Booker, Commercial Manager at Milton Park, said: “Providing spaces for life sciences companies at the forefront of innovation is at the heart of what we do at Milton Park, so we‘re absolutely delighted to offer a site to Exscientia as their plans for growth come to life. “
“Exscientia’s pioneering use of AI technology to make the discovery of medicines more efficient is perhaps more pertinent than ever in light of COVID-19. We’re very pleased to welcome Exscientia to the Milton Park community at what is an exciting point in their evolution.”